- 15 Marks
Question
Prepare a Consolidated Statement of Profit or Loss and Other Comprehensive Income for the Sekyedumase Group for the year ended 31 March 2025 in accordance with IFRS.
Answer
Sekyedumase Group
Consolidated Statement of Profit or Loss and Other Comprehensive Income
for the year ended 31 March 2025
| GH¢ million | |
|---|---|
| Revenue | 186.00 |
| Cost of Sales | (79.72) |
| Gross Profit | 106.28 |
| Operating expenses | (35.20) |
| Finance costs | (6.44) |
| Other income | 0.00 |
| Dividends received | 0.00 |
| Income from Associate | 0.48 |
| Profit before taxation | 65.12 |
| Taxation | (6.94) |
| Profit for the year | 58.18 |
Other Comprehensive Income (not reclassified to profit or loss):
| GH¢ million | |
|---|---|
| Gains on remeasurement of financial assets | 2.60 |
| Total comprehensive income | 60.78 |
Profit attributable to:
-
Owners of the parent: 58.04
-
Non-controlling interest: 0.14
Total comprehensive income attributable to:
-
Owners of the parent: 60.80
-
Non-controlling interest: (0.02)
- Tags: Consolidation, IAS 28, IFRS 10, Intragroup Transactions, OCI
- Level: Level 2
- Uploader: Samuel Duah